(Q34286341)

1 August 2017

title

Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells (English)

1 reference

1 August 2017

0 references

Jin Sun Lee

1

1 reference

1 August 2017

Ji Young Sul

2

1 reference

1 August 2017

Jun Beom Park

3

1 reference

1 August 2017

Myung Sun Lee

4

1 reference

1 August 2017

Eun Young Cha

5

1 reference

1 August 2017

In Sang Song

6

1 reference

1 August 2017

Je Ryong Kim

7

1 reference

1 August 2017

Eil Sung Chang

8

1 reference

1 August 2017

publication date

5 July 2012

1 reference

1 August 2017

published in

Phytotherapy Research

1 reference

1 August 2017

volume

27

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

713-720

1 reference

Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation

1 August 2017

cites work

1 reference

Inhibition of tumor specific angiogenesis by amentoflavone

21 January 2018

1 reference

Fatty acid synthase and cancer: new application of an old pathway

21 January 2018

1 reference

Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells

21 January 2018

1 reference

Biologic and therapeutic role of HER2 in cancer

21 January 2018

1 reference

Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene

21 January 2018

1 reference

Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells.

21 January 2018

1 reference

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

21 January 2018

1 reference

Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer

21 January 2018

1 reference

Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.

21 January 2018

1 reference

The SREBP pathway--insights from Insigs and insects

21 January 2018

1 reference

Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer.

21 January 2018

1 reference

A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol

21 January 2018

1 reference

Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling

21 January 2018

1 reference

The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis

21 January 2018

1 reference

Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase

21 January 2018

1 reference

Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c

21 January 2018

1 reference

Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells.

21 January 2018

1 reference

Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer

21 January 2018

1 reference

Fatty acid synthase: a novel target for antiglioma therapy

21 January 2018

1 reference

Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PTR.4778

1 reference

1 August 2017

1 reference